29914956-figure-01 (29914956 Figure 01)
Fosinopril Sodium
Product Images NDC 50436-3138
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium (NDC 50436-3138). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
29914956-figure-02 (29914956 Figure 02)
This is a table presenting clinical adverse events in placebo-controlled trials for hypertension medications Fosinopril Sodium and Placebo. The table indicates the incidence of common side effects such as cough, dizziness, and nausea/vomiting and the number of patients who discontinued medication due to the side effects.*
29914956-figure-03 (29914956 Figure 03)
This is a description of the incidence of adverse events in placebo-controlled trials related to heart failure. The table lists the number of patients and incidence rates for six adverse events. These include dizziness, cough, hypotension, musculoskeletal pain, nausea/vomiting, and diarrhea. The table also includes the number of patients who discontinued the treatment and the reason for discontinuation.*
29914956-figure-04 (29914956 Figure 04)
The text provides information on the incidence of adverse events and discontinuation rates associated with Fosinopril Sodium Placebo. It shows the occurrence and frequency of different side effects such as Chest Pain (non-cardiac), Upper Respiratory Infection, Orthostatic Hypotension, Subjective Cardiac Rhythm Disturbance, and Weakness. The incidence rates are provided for two groups of participants (N=361 and N=373).*
Label Image (50436 3138)
This is a medication description likely retrieved from a prescription label. The medication is Fosinopril Sodium, with a strength of 20mg. It is manufactured by a company named Camber and has a National Drug Code (NDC) of 50436-3138-1. The remaining text appears to be one gibberish and not-English, possibly due to errors.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
